X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,406 | 121,718 | 79,855 | 47,378 | 66,427 |
| Receivables | 658 | 1,152 | 909 | 843 | 868 |
| TOTAL | $98,222 | $128,677 | $85,718 | $52,585 | $70,881 |
| Non-Current Assets | |||||
| PPE Net | 986 | 1,104 | 1,194 | 1,309 | 1,403 |
| Intangibles | 17,351 | 17,351 | 17,351 | 17,351 | 17,351 |
| Other Non-Current Assets | 7,846 | 8,454 | 9,143 | 9,774 | 9,990 |
| TOTAL | $26,183 | $26,909 | $27,688 | $28,434 | $28,744 |
| Total Assets | $124,405 | $155,586 | $113,406 | $81,019 | $99,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 554 | 1,315 | 14,621 | 8,607 | 3,415 |
| Accounts payable and accrued liabilities | 5,992 | 7,777 | 3,800 | 3,677 | 3,569 |
| Accrued Expenses | 11,762 | 12,034 | 9,128 | 8,582 | 6,877 |
| TOTAL | $19,483 | $22,324 | $28,713 | $22,002 | $14,970 |
| Non-Current Liabilities | |||||
| Long Term Debt | 31,827 | 32,304 | 18,733 | 24,490 | 29,809 |
| Other Non-Current Liabilities | 21,419 | 26,907 | 4,111 | 4,454 | 5,132 |
| TOTAL | $53,246 | $59,211 | $22,844 | $28,944 | $34,941 |
| Total Liabilities | $72,729 | $81,535 | $51,557 | $50,946 | $49,911 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,070 | 4,070 | 2,306 | 2,286 | 1,026 |
| Common Shares | 122 | 122 | 69 | 31 | 31 |
| Retained earnings | -400,758 | -376,738 | -347,634 | -326,048 | -304,836 |
| Other shareholders' equity | -119 | -119 | -119 | -119 | -119 |
| TOTAL | $51,676 | $74,051 | $61,849 | $30,073 | $49,714 |
| Total Liabilities And Equity | $124,405 | $155,586 | $113,406 | $81,019 | $99,625 |